{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:45:27Z","timestamp":1786981527240,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guizhou Administration of Traditional Chinese Medicine Program","award":["QZYY2022029"],"award-info":[{"award-number":["QZYY2022029"]}]},{"name":"Guizhou Science and Technology Plan Basic Research Projects","award":["zk2025517"],"award-info":[{"award-number":["zk2025517"]}]},{"name":"Scientific and Technological Fund Project of Guizhou Provincial Health Commission","award":["gzwkj 2025-105"],"award-info":[{"award-number":["gzwkj 2025-105"]}]},{"name":"Horizontal Research Project of the Affiliated Stomatological Hospital of Guizhou Medical University: Application of 3D Digital Guides in Microscopic Apical Surgery","award":["GYKQ2022HX01"],"award-info":[{"award-number":["GYKQ2022HX01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11046-026-01092-3","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:32:59Z","timestamp":1784777579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synergistic Effects of Cepharanthine and Amphotericin B Against Candida albicans by Targeting PMP3-Mediated Sphingolipid Biosynthesis and Membrane Disruption"],"prefix":"10.1007","volume":"191","author":[{"given":"Song","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinlan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengguang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"issue":"7","key":"1092_CR1","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024;24(7):e428\u201338.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"1092_CR2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00142-23","volume":"37","author":"E Puumala","year":"2024","unstructured":"Puumala E, Fallah S, Robbins N, et al. Advancements and challenges in antifungal therapeutic development. Clin Microbiol Rev. 2024;37(1):e0014223.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"1092_CR3","first-page":"369","volume":"105","author":"DA Randall","year":"2022","unstructured":"Randall DA, Wilson Westmark NL, Neville BW. Common Oral Lesions. Am Fam Physician. 2022;105(4):369\u201376.","journal-title":"Am Fam Physician"},{"key":"1092_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mib.2020.05.006","volume":"56","author":"CA Kumamoto","year":"2020","unstructured":"Kumamoto CA, Gresnigt MS, Hube B. The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine. Curr Opin Microbiol. 2020;56:7\u201315.","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"1092_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00428-023-03628-0","volume":"483","author":"O Winocur-Arias","year":"2023","unstructured":"Winocur-Arias O, Zlotogorski-Hurvitz A, Ben-Zvi Y, et al. The profile of chronic hyperplastic candidiasis: a clinico-pathological study. Virchows Arch. 2023;483(4):527\u201334.","journal-title":"Virchows Arch"},{"issue":"8","key":"1092_CR6","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1016\/j.apsb.2021.04.010","volume":"11","author":"X Wang","year":"2021","unstructured":"Wang X, Mohammad IS, Fan L, et al. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharm Sin B. 2021;11(8):2585\u2013604.","journal-title":"Acta Pharm Sin B"},{"issue":"6","key":"1092_CR7","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1086\/313498","volume":"29","author":"JR Wingard","year":"1999","unstructured":"Wingard JR, Kubilis P, Lee L, et al. Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis. 1999;29(6):1402\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"1092_CR8","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1128\/AAC.43.4.836","volume":"43","author":"SA Yoon","year":"1999","unstructured":"Yoon SA, Vazquez JA, Steffan PE, et al. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance. Antimicrob Agents Chemother. 1999;43(4):836\u201345.","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 4","key":"1092_CR9","doi-asserted-by":"publisher","first-page":"S260","DOI":"10.1093\/cid\/ciz076","volume":"68","author":"AH Groll","year":"2019","unstructured":"Groll AH, Rijnders BJA, Walsh TJ, et al. Clinical pharmacokinetics, pharmacodynamics, safety and efficacy of liposomal amphotericin B. Clin Infect Dis. 2019;68(Suppl 4):S260\u201374.","journal-title":"Clin Infect Dis"},{"key":"1092_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114874","volume":"198","author":"P Zhu","year":"2023","unstructured":"Zhu P, Li Y, Guo T, et al. New antifungal strategies: Drug combination and co-delivery. Adv Drug Deliv Rev. 2023;198:114874.","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"1092_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004975","volume":"12","author":"X Chen","year":"2016","unstructured":"Chen X, Ren B, Chen M, et al. NLLSS: Predicting Synergistic Drug Combinations Based on Semi-supervised Learning. PLoS Comput Biol. 2016;12(7):e1004975.","journal-title":"PLoS Comput Biol"},{"issue":"12","key":"1092_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202200148","volume":"6","author":"H Fan","year":"2022","unstructured":"Fan H, He ST, Han P, et al. Cepharanthine: a Promising Old Drug against SARS-CoV-2. Adv Biol (Weinh). 2022;6(12):e2200148.","journal-title":"Adv Biol (Weinh)"},{"issue":"4","key":"1092_CR13","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1159\/000471234","volume":"41","author":"S Gao","year":"2017","unstructured":"Gao S, Li X, Ding X, et al. Cepharanthine induces autophagy, apoptosis and cell cycle arrest in breast cancer cells. Cell Physiol Biochem. 2017;41(4):1633\u201348.","journal-title":"Cell Physiol Biochem"},{"issue":"14","key":"1092_CR14","first-page":"2429","volume":"18","author":"M Nishiyama","year":"1991","unstructured":"Nishiyama M, Aogi K, Saeki S, et al. Combination of a biscoclaurine alkaloid, cepharanthine, and anticancer agents: effects and mechanism in human gastric and pancreatic carcinoma cell lines. Gan To Kagaku Ryoho. 1991;18(14):2429\u201333.","journal-title":"Gan To Kagaku Ryoho"},{"issue":"2","key":"1092_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10753-013-9744-6","volume":"37","author":"Z Ershun","year":"2014","unstructured":"Ershun Z, Yunhe F, Zhengkai W, et al. Cepharanthine attenuates lipopolysaccharide-induced mice mastitis by suppressing the NF-\u03baB signaling pathway. Inflammation. 2014;37(2):331\u20137.","journal-title":"Inflammation"},{"issue":"1-3","key":"1092_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejphar.2012.02.030","volume":"683","author":"YB Zhou","year":"2012","unstructured":"Zhou YB, Wang YF, Zhang Y, et al. In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates. Eur J Pharmacol. 2012;683(1\u20133):10\u20135.","journal-title":"Eur J Pharmacol"},{"key":"1092_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105143","volume":"193","author":"Y Liu","year":"2021","unstructured":"Liu Y, Tang Q, Rao Z, et al. Inhibition of herpes simplex virus 1 by cepharanthine via promoting cellular autophagy through up-regulation of STING\/TBK1\/P62 pathway. Antiviral Res. 2021;193:105143.","journal-title":"Antiviral Res"},{"issue":"4","key":"1092_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102367","volume":"24","author":"H Ohashi","year":"2021","unstructured":"Ohashi H, Watashi K, Saso W, et al. Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatment. iScience. 2021;24(4):102367.","journal-title":"iScience"},{"issue":"2","key":"1092_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF00328721","volume":"198","author":"AM Gillum","year":"1984","unstructured":"Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5\u2032-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet. 1984;198(2):179\u201382.","journal-title":"Mol Gen Genet"},{"key":"1092_CR20","unstructured":"Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard\u2014Third Edition [R]. CLSI document M27-A3, Vol. 28 No. 14. Wayne, PA: Clinical and Laboratory Standards Institute; 2008."},{"key":"1092_CR21","doi-asserted-by":"publisher","first-page":"533209","DOI":"10.3389\/fmicb.2020.533209","volume":"11","author":"C Zhou","year":"2020","unstructured":"Zhou C, Wang Q, Jin L, et al. In vitro Synergistic activity of antimicrobial combinations against blaKPC and blaNDM-producing enterobacterales with blaIMP or mcr genes. Front Microbiol. 2020;11:533209.","journal-title":"Front Microbiol"},{"issue":"1","key":"1092_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother. 2003;52(1):1.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1092_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41368-023-00245-0","volume":"15","author":"X Liang","year":"2023","unstructured":"Liang X, Chen D, Wang J, et al. Artemisinins inhibit oral candidiasis caused by Candida albicans through the repression on its hyphal development. Int J Oral Sci. 2023;15(1):40.","journal-title":"Int J Oral Sci"},{"key":"1092_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.780545","volume":"11","author":"A Priya","year":"2021","unstructured":"Priya A, Nivetha S, Pandian SK. Synergistic interaction of piperine and thymol on attenuation of the biofilm formation, hyphal morphogenesis and phenotypic switching in Candida albicans. Front Cell Infect Microbiol. 2021;11:780545.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"1092_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-023-01587-y","volume":"13","author":"J Zhang","year":"2023","unstructured":"Zhang J, Sun J, Zhang Y, et al. Dehydrocostus lactone inhibits Candida albicans growth and biofilm formation. AMB Express. 2023;13(1):82.","journal-title":"AMB Express"},{"issue":"5","key":"1092_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1042\/BCJ20161039","volume":"474","author":"H Lee","year":"2017","unstructured":"Lee H, Hwang JS, Lee DG. Scolopendin, an antimicrobial peptide from centipede, attenuates mitochondrial functions and triggers apoptosis in Candida albicans. Biochem J. 2017;474(5):635\u201345.","journal-title":"Biochem J"},{"issue":"12","key":"1092_CR27","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1111\/bph.16333","volume":"181","author":"M Liao","year":"2024","unstructured":"Liao M, Xia X, Meng Q, et al. Holotoxin A(1) from Apostichopus japonicus inhibited oropharyngeal and intra-abdominal candidiasis by inducing oxidative damage in Candida albicans. Br J Pharmacol. 2024;181(12):1857\u201373.","journal-title":"Br J Pharmacol"},{"issue":"3","key":"1092_CR28","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1248\/bpb.b20-00246","volume":"44","author":"X Yang","year":"2021","unstructured":"Yang X, Pei Z, Hu R, et al. Study on the inhibitory activity and possible mechanism of myriocin on clinically relevant drug-resistant Candida albicans and its biofilms. Biol Pharm Bull. 2021;44(3):305\u201315.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"1092_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106394","volume":"58","author":"C Zhu","year":"2021","unstructured":"Zhu C, Liao B, Ye X, et al. Artemisinin elevates ergosterol levels of Candida albicans to synergise with amphotericin B against oral candidiasis. Int J Antimicrob Agents. 2021;58(3):106394.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"1092_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.mycmed.2019.100899","volume":"29","author":"M Sohaib Shahzan","year":"2019","unstructured":"Sohaib Shahzan M, Smiline Girija AS, Vijayashree Priyadharsini J. A computational study targeting the mutated L321F of ERG11 gene in C. albicans, associated with fluconazole resistance with bioactive compounds from Acacia nilotica. J Mycol Med. 2019;29(4):303\u20139.","journal-title":"J Mycol Med"},{"issue":"2","key":"1092_CR31","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrmicro.2016.157","volume":"15","author":"SM Noble","year":"2017","unstructured":"Noble SM, Gianetti BA, Witchley JN. Candida albicans cell-type switching and functional plasticity in the mammalian host. Nat Rev Microbiol. 2017;15(2):96\u2013108.","journal-title":"Nat Rev Microbiol"},{"key":"1092_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed7080188","author":"D Yamin","year":"2022","unstructured":"Yamin D, Akanmu MH, Al Mutair A, et al. Global prevalence of antifungal-resistant Candida parapsilosis: a systematic review and meta-analysis. Trop Med Infect Dis. 2022. https:\/\/doi.org\/10.3390\/tropicalmed7080188.","journal-title":"Trop Med Infect Dis"},{"key":"1092_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.simyco.2021.100115","volume":"100","author":"A Arastehfar","year":"2021","unstructured":"Arastehfar A, Carvalho A, Houbraken J, et al. Aspergillus fumigatus and aspergillosis: from basics to clinics. Stud Mycol. 2021;100:100115.","journal-title":"Stud Mycol"},{"issue":"1","key":"1092_CR34","doi-asserted-by":"publisher","first-page":"2398596","DOI":"10.1080\/22221751.2024.2398596","volume":"13","author":"S Tian","year":"2024","unstructured":"Tian S, Rong C, Li H, et al. Genetic microevolution of clinical Candida auris with reduced Amphotericin B sensitivity in China. Emerg Microbes Infect. 2024;13(1):2398596.","journal-title":"Emerg Microbes Infect"},{"key":"1092_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12050884","author":"A Carmo","year":"2023","unstructured":"Carmo A, Rocha M, Pereirinha P, et al. Antifungals: from pharmacokinetics to clinical practice. Antibiotics (Basel). 2023. https:\/\/doi.org\/10.3390\/antibiotics12050884.","journal-title":"Antibiotics (Basel)"},{"issue":"Suppl 1","key":"1092_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/jac\/49.suppl_1.7","volume":"49","author":"D Ellis","year":"2002","unstructured":"Ellis D. Amphotericin B: spectrum and resistance. J Antimicrob Chemother. 2002;49(Suppl 1):7\u201310.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"1092_CR37","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s40121-020-00382-7","volume":"10","author":"FB Cavassin","year":"2021","unstructured":"Cavassin FB, Ba\u00fa-Carneiro JL, Vilas-Boas RR, et al. Sixty years of amphotericin B: an overview of the main antifungal agent used to treat invasive fungal infections. Infect Dis Ther. 2021;10(1):115\u201347.","journal-title":"Infect Dis Ther"},{"issue":"5","key":"1092_CR38","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1128\/IAI.01841-06","volume":"75","author":"J Chandra","year":"2007","unstructured":"Chandra J, McCormick TS, Imamura Y, et al. Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines. Infect Immun. 2007;75(5):2612\u201320.","journal-title":"Infect Immun"},{"issue":"2","key":"1092_CR39","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/iub.1973","volume":"71","author":"S Kim","year":"2019","unstructured":"Kim S, Woo ER, Lee DG. Synergistic antifungal activity of isoquercitrin: apoptosis and membrane permeabilization related to reactive oxygen species in Candida albicans. IUBMB Life. 2019;71(2):283\u201392.","journal-title":"IUBMB Life"},{"issue":"3","key":"1092_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bbrc.2019.08.053","volume":"518","author":"SN Khan","year":"2019","unstructured":"Khan SN, Khan S, Misba L, et al. Synergistic fungicidal activity with low doses of eugenol and amphotericin B against Candida albicans. Biochem Biophys Res Commun. 2019;518(3):459\u201364.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"1092_CR41","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/emboj\/19.11.2515","volume":"19","author":"C Navarre","year":"2000","unstructured":"Navarre C, Goffeau A. Membrane hyperpolarization and salt sensitivity induced by deletion of PMP3, a highly conserved small protein of yeast plasma membrane. EMBO J. 2000;19(11):2515\u201324.","journal-title":"EMBO J"},{"issue":"2","key":"1092_CR42","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.celrep.2013.01.019","volume":"3","author":"Z Huang","year":"2013","unstructured":"Huang Z, Chen K, Zhang J, et al. A functional variomics tool for discovering drug-resistance genes and drug targets. Cell Rep. 2013;3(2):577\u201385.","journal-title":"Cell Rep"},{"key":"1092_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/srep09685","volume":"5","author":"VK Bari","year":"2015","unstructured":"Bari VK, Sharma S, Alfatah M, et al. Plasma membrane proteolipid 3 protein modulates amphotericin B resistance through sphingolipid biosynthetic pathway. Sci Rep. 2015;5:9685.","journal-title":"Sci Rep"},{"issue":"7","key":"1092_CR44","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1073\/pnas.97.7.3254","volume":"97","author":"M Bagnat","year":"2000","unstructured":"Bagnat M, Ker\u00e4nen S, Shevchenko A, et al. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad Sci U S A. 2000;97(7):3254\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1092_CR45","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ceb.2022.01.006","volume":"74","author":"C K\u00f6rner","year":"2022","unstructured":"K\u00f6rner C, Fr\u00f6hlich F. Compartmentation and functions of sphingolipids. Curr Opin Cell Biol. 2022;74:104\u201311.","journal-title":"Curr Opin Cell Biol"},{"issue":"10","key":"1092_CR46","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1128\/jb.173.10.3101-3108.1991","volume":"173","author":"JL Patton","year":"1991","unstructured":"Patton JL, Lester RL. The phosphoinositol sphingolipids of Saccharomyces cerevisiae are highly localized in the plasma membrane. J Bacteriol. 1991;173(10):3101\u20138.","journal-title":"J Bacteriol"},{"issue":"10","key":"1092_CR47","doi-asserted-by":"publisher","first-page":"a004697","DOI":"10.1101\/cshperspect.a004697","volume":"3","author":"K Simons","year":"2011","unstructured":"Simons K, Sampaio JL. Membrane organization and lipid rafts. Cold Spring Harb Perspect Biol. 2011;3(10):a004697.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"39","key":"1092_CR48","doi-asserted-by":"publisher","first-page":"30224","DOI":"10.1074\/jbc.M110.123554","volume":"285","author":"C Klose","year":"2010","unstructured":"Klose C, Ejsing CS, Garc\u00eda-S\u00e1ez AJ, et al. Yeast lipids can phase-separate into micrometer-scale membrane domains. J Biol Chem. 2010;285(39):30224\u201332.","journal-title":"J Biol Chem"},{"issue":"9","key":"1092_CR49","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/AAC.02268-18","volume":"63","author":"C Balkan","year":"2019","unstructured":"Balkan C, Ercan I, Isik E, et al. Genomewide Elucidation of Drug Resistance Mechanisms for Systemically Used Antifungal Drugs Amphotericin B, Caspofungin, and Voriconazole in the Budding Yeast. Antimicrob Agents Chemother. 2019;63(9):10\u20131128.","journal-title":"Antimicrob Agents Chemother"},{"key":"1092_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/srep40281","volume":"7","author":"M Alfatah","year":"2017","unstructured":"Alfatah M, Bari VK, Nahar AS, et al. Critical role for CaFEN1 and CaFEN12 of Candida albicans in cell wall integrity and biofilm formation. Sci Rep. 2017;7:40281.","journal-title":"Sci Rep"},{"issue":"1","key":"1092_CR51","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1038\/s41467-018-06944-1","volume":"9","author":"J Gao","year":"2018","unstructured":"Gao J, Wang H, Li Z, et al. Candida albicans gains azole resistance by altering sphingolipid composition. Nat Commun. 2018;9(1):4495.","journal-title":"Nat Commun"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01092-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-026-01092-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-026-01092-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T06:02:11Z","timestamp":1785564131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-026-01092-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s11046-026-01092-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9714769\/v1","asserted-by":"object"}]},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"14 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval and patient consent were not required, as the clinical isolates were derived from anonymized clinical samples collected during routine laboratory activities.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"67"}}